Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)
(PAR-21-305)
National Institute of Diabetes and Digestive and Kidney Diseases
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of Disease Prevention
Application Receipt Date(s): September 22, 2021; October 14, 2021; November 9, 2021; December 9, 2021; January 10, 2022; February 10, 2022; March 10, 2022;
April 11, 2022; May 10, 2022; June 9, 2022; July 11, 2022; August 9, 2022; September 9, 2022; October 7, 2022; November 9, 2022; December 9, 2022;
January 10, 2023; February 9, 2023; March 9, 2023; April 11, 2023; May 9, 2023; June 9, 2023; July 11, 2023; August 9, 2023; September 8, 2023;
October 10, 2023; November 9, 2023; December 11, 2023; January 9, 2024; February 9, 2024; March 8, 2024; April 9, 2024;
May 8, 2024; June 10, 2024, July 9, 2024; August 9, 2024; and September 10, 2024
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
American Women: Assessing Risk Epidemiologically (AWARE) (R01 Clinical Trial Optional)
(RFA-AI-21-058)
National Institute of Allergy and Infectious Diseases
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
Office of Research on Women's Health
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): Not Applicable